The majority of Hizentra patients with commercial insurance pay $0 out‑of‑pocket

The Hizentra Co‑Pay Relief program helps people who are eligible afford their therapy by helping with monthly out‑of‑pocket expenses for Hizentra (up to $5,000 for each year, with no monthly cap*).

Plus, it’s easy to enroll! If you are interested in receiving co-pay assistance, just call IgIQ and ask.

See terms and conditions below.

See how Co-Pay Relief can help you and your family

Looking to sign up now or for more information? Call IgIQ at 1-877-355-IGIQ (4447) Mon–Fri, 8 AM–8 PM ET.

*Other terms and conditions may apply. This program applies to product costs only. Contact IgIQ to learn more.

Terms and Conditions

  • Prescription must be for primary immunodeficiency or chronic inflammatory demyelinating polyneuropathy diagnosis
  • Patients with PI must be at least 2 years of age and CIDP patients must be 18 or older
  • Patient must be receiving Hizentra through a Specialty Pharmacy or physician office
  • It is recommended that the patient use a Specialty Pharmacy provider that is in-network with the patient's current plan
  • Patient must express financial need
  • Patient must have coverage for the product under a private US insurance plan. Not valid for prescriptions eligible for reimbursement by any federal or state healthcare program, such as Medicare, Medicare advantage plans, Medicaid, PCIP, Champus, TriCare, Veterans Administration (VA), or any other state or federal program
  • Patients whose insurance policy prohibits co-pay assistance are not eligible. Prior to enrolling in this CSL Behring program. participants are responsible for checking with their insurance carrier to confirm that their participation is not inconsistent with their insurance carrier's requirements
  • This program is subject to change or discontinuation by CSL Behring at any time, for any reason, and with or without prior notice
You are now leaving the current website.

Do you want to continue?

No Yes